EFFICACY AND SAFETY OF ABT-126, AN A7 NICOTINIC CHOLINERGIC AGONIST, IN TREATMENT OF COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA: RESULTS FROM A PHASE 2B STUDY IN SMOKERS
SCHIZOPHRENIA BULLETIN(2015)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要